Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 4504
Gene Symbol: MT3
MT3
0.010 AlteredExpression disease BEFREE MT1A, MT1E, MT1X, MT2, MT3 gene expression was elevated in grade IV astrocytomas (glioblastomas) as compared to astrocytomas grade I-III. 30932010 2019
Entrez Id: 4501
Gene Symbol: MT1X
MT1X
0.010 AlteredExpression disease BEFREE MT1A, MT1E, MT1X, MT2, MT3 gene expression was elevated in grade IV astrocytomas (glioblastomas) as compared to astrocytomas grade I-III. 30932010 2019
Entrez Id: 255231
Gene Symbol: MCOLN2
MCOLN2
0.010 AlteredExpression disease BEFREE TRPML-2 mRNA and protein levels increased with the pathological grade, starting from pylocitic astrocytoma (grade I) to glioblastoma (grade IV). 27248469 2016
Entrez Id: 10512
Gene Symbol: SEMA3C
SEMA3C
0.010 AlteredExpression disease BEFREE Western blot analysis was used for detection of Sema3C protein levels in 84 different grade glioma samples: 12 grade I astrocytomas, 30 grade II astrocytomas, 17 grade III astrocytomas, and 25 grade IV astrocytomas (glioblastomas). 26032848 2015
Entrez Id: 3417
Gene Symbol: IDH1
IDH1
0.010 Biomarker disease BEFREE Wild-type (WT) IDH1 was detected in cases with a World Health Organization (WHO) grade I astrocytoma. 23934769 2014
Entrez Id: 64083
Gene Symbol: GOLPH3
GOLPH3
0.010 AlteredExpression disease BEFREE The highest mean value of GOLPH3 mRNA and protein was found in patients with glioblastoma (P < 0.01) whereas the lowest mean values were found in those with grade I astrocytoma (P < 0.01). 21499727 2011
Entrez Id: 644943
Gene Symbol: RASSF10
RASSF10
0.010 PosttranslationalModification disease BEFREE RASSF10 was frequently methylated in WHO grade II-III astrocytomas and WHO grade IV primary glioblastomas (67.5%), but was unmethylated in grade I astrocytomas and in DNA from age matched control brain samples. 20956940 2011
Entrez Id: 1956
Gene Symbol: EGFR
EGFR
0.010 AlteredExpression disease BEFREE Grade I astrocytomas presented gene expression levels similar to those encountered in samples of microdissected white matter of non-neoplastic brain tissue Overexpression of the EGFR, IGFBP-2 and HIF-2A genes was significantly associated with lower 2-year survival (P: 0.009, P: 0.0002 and P: 0.008, respectively). 17285230 2007
Entrez Id: 7089
Gene Symbol: TLE2
TLE2
0.010 AlteredExpression disease BEFREE Interestingly, a group of 6 genes (TIMP4, C1NH, CHAD, THBS4, IGFBP2, and TLE2) constitute an expression profile characteristic of grade I astrocytomas as compared with all other categories of tissue (normal brain, grade II, and high-grade astrocytomas). 16896313 2006
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.230 Biomarker disease CTD_mouse Bioluminescent approaches for measuring tumor growth in a mouse model of neurofibromatosis. 20176786 2010
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.230 GeneticVariation disease BEFREE In this study we have analysed 47 cases of astrocytic tumours (26 glioblastomas [grade IV], 11 anaplastic astrocytomas [grade III], seven fibrillary astrocytomas [grade II] and three pilocytic astrocytomas [grade I]) for the presence of allelic imbalance at the p53 gene locus using intragenic markers. 7494603 1995
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.230 Biomarker disease BEFREE Fifteen of 47 (32%) grade IV were p53 immunopositive, as were 3/16 (19%) grade III, 0/7 (0%) grade II and 0/4 (0%) grade I astrocytomas. 7632359 1995
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.230 GeneticVariation disease BEFREE Five of the 11 grade III astrocytomas (glioblastoma multiforme), but only one of seven grade II astrocytomas (anaplastic astrocytoma) and none of either the grade I astrocytomas or oligodendrogliomas demonstrated distinct point mutations involving the TP53 gene. 1686725 1991
Entrez Id: 2099
Gene Symbol: ESR1
ESR1
0.300 Biomarker disease CTD_human Expression of estrogen receptors, androgen receptor and steroid receptor coactivator-3 is negatively correlated to the differentiation of astrocytic tumors. 24680642 2014
Entrez Id: 367
Gene Symbol: AR
AR
0.300 Biomarker disease CTD_human Expression of estrogen receptors, androgen receptor and steroid receptor coactivator-3 is negatively correlated to the differentiation of astrocytic tumors. 24680642 2014
Entrez Id: 2100
Gene Symbol: ESR2
ESR2
0.300 Biomarker disease CTD_human Expression of estrogen receptors, androgen receptor and steroid receptor coactivator-3 is negatively correlated to the differentiation of astrocytic tumors. 24680642 2014
Entrez Id: 90
Gene Symbol: ACVR1
ACVR1
0.300 Biomarker disease CTD_human Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma. 24705250 2014
Entrez Id: 8202
Gene Symbol: NCOA3
NCOA3
0.300 Biomarker disease CTD_human Expression of estrogen receptors, androgen receptor and steroid receptor coactivator-3 is negatively correlated to the differentiation of astrocytic tumors. 24680642 2014
Entrez Id: 57670
Gene Symbol: KIAA1549
KIAA1549
0.300 Biomarker disease CTD_human Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma. 23817572 2013
Entrez Id: 2260
Gene Symbol: FGFR1
FGFR1
0.300 Biomarker disease CTD_human Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma. 23817572 2013
Entrez Id: 5781
Gene Symbol: PTPN11
PTPN11
0.300 Biomarker disease CTD_human Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma. 23817572 2013
Entrez Id: 4763
Gene Symbol: NF1
NF1
0.300 Biomarker disease CTD_human Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma. 23817572 2013
Entrez Id: 4915
Gene Symbol: NTRK2
NTRK2
0.300 Biomarker disease CTD_human Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma. 23817572 2013
Entrez Id: 673
Gene Symbol: BRAF
BRAF
0.300 Biomarker disease CTD_human Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma. 23817572 2013
Entrez Id: 3845
Gene Symbol: KRAS
KRAS
0.300 Biomarker disease CTD_human Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma. 23817572 2013